EASTMAN CHEMICAL CO Other Asset Impairment Charges
EASTMAN CHEMICAL CO (EMN) reported Other Asset Impairment Charges of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2025-02-14
- EASTMAN CHEMICAL CO other asset impairment charges for the quarter ending 2022-12-31 was $0.00.
- EASTMAN CHEMICAL CO other asset impairment charges for the quarter ending 2022-09-30 was $0.00.
- EASTMAN CHEMICAL CO other asset impairment charges for the quarter ending 2022-06-30 was $15.00M.
- EASTMAN CHEMICAL CO other asset impairment charges for the quarter ending 2022-03-31 was $0.00.
- EASTMAN CHEMICAL CO other asset impairment charges for fiscal 2024 was $0.00.
- EASTMAN CHEMICAL CO other asset impairment charges for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- EASTMAN CHEMICAL CO other asset impairment charges for fiscal 2022 was $15.00M.
- EASTMAN CHEMICAL CO other asset impairment charges for fiscal 2021 was -$1.00M.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-14 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $15.00M derived: sum of 3 quarters · filed 2025-02-14 | $15.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-28 | $15.00M derived: sum of 2 quarters · filed 2022-10-28 | $15.00M 10-Q · filed 2022-10-28 | $15.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-01 | $15.00M 10-Q · filed 2022-08-01 | $15.00M derived: sum of 3 quarters · filed 2024-02-14 | $15.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-14 | $0.00 derived: sum of 3 quarters · filed 2024-02-14 | $0.00 derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $0.00 derived: sum of 2 quarters · filed 2024-02-14 | $0.00 derived: sum of 3 quarters · filed 2024-02-14 | -$1.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | -$1.00M 10-Q · filed 2022-10-28 | -$1.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-01 | -$1.00M 10-Q · filed 2022-08-01 | -$1.00M derived: sum of 3 quarters · filed 2023-02-15 | -$1.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | -$1.00M 10-Q · filed 2022-05-04 | -$1.00M derived: sum of 2 quarters · filed 2023-02-15 | -$1.00M derived: sum of 3 quarters · filed 2023-02-15 | -$1.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $0.00 derived: sum of 2 quarters · filed 2023-02-15 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | $0.00 10-K · filed 2023-02-15 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-01 | $0.00 derived: sum of 2 quarters · filed 2021-11-01 | $0.00 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |
| DuPont de Nemours, Inc. (DD) | United States | $17.580B | 1,010.90 |
| DOW INC. (DOW) | United States | $20.577B | -11.55 |